Male Breast Cancer?A Reappraisal of Clinical and Biologic Indicators of Prognosis

References

• Tavassoli FA. Pathology of the breast, 2nd ed. Connecticut Appleton & Lange, 1999: 837.
   Google Scholar
• Ravendi-Kashani F, Hayes TG. Male breast cancer: a review of the literature. Eur J Cancer 1998; 9: 1341–7.
   Google Scholar
• Incidência e Mortalidade no Registo Oncológico Regional Sul, Lisboa, 1997: 7.
   Google Scholar
• American Joint Committee on Cancer. In: Beahrs OH, Hen-son DE, Hutter RVP, Kennedy BJ, eds. Manual for staging of cancer. 5th ed. Philadelphia: JB Lippincott, 1997.
   Google Scholar
• Gateley CA. Male breast disease. The Breast 1998; 7: 121–7.
   Google Scholar
• Guinee VF, Olsson H, Moller T, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993; 71: 154–61.
   Google Scholar
• Vetto J, Jun SY, Padduch D, Eppich H, Shih R. Stages at presentation, prognostic factors, and outcome of breast can-cer in males. Am J Surg 1999; 177: 379–83.
   Google Scholar
• Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma. A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Can-cer 1999; 85: 629–39.
   Google Scholar
• Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995; 31A: 1960–4.
   PubMed Web of Science ®Google Scholar
• Willsher PC, Leach IH, Ellis JO, et al. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 1997; 173: 185–8.
   PubMed Web of Science ®Google Scholar
• Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surgeon 2000; 66: 502–11.
   Google Scholar
• Joshi GM, Lee AKC, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77: 490–8.
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis JO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–10.
   Google Scholar
• Pich A, Margaria E, Chiusa L, Ponti R, Geuna M. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Hum Pathol 1996; 27: 676–82.
   Google Scholar
• Colleoni M, Orvieto E, Nolé F, et al. Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 1999; 35: 574–9.
   PubMedGoogle Scholar
• Auer G, Askensten U, Ahrens A. Cytophotometry. Hum Pathol 1989; 20: 518–27.
   PubMed Web of Science ®Google Scholar
• Hedley DW, Clark GM, Comelisse CJ, et al. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993; 14: 482–5.
   PubMedGoogle Scholar
• Dean PN, Jett JH. Mathematical analysis of DNA distribu-tions derived from flow microfluorometry. J Cell Biol 1974; 60: 523–7.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incom-plete observations. J Am Stat Assoc 1958; 53: 457–81.
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966; 50: 163–70.
   PubMedGoogle Scholar
• Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187–220.
   Google Scholar
• Mejias A, Sittler S, Mies C. Poor prognosis features are prevalent in young men with breast carcinoma. Mod Pathol 1994; 7: 18A.
   Google Scholar
• Hill A, Yagmur Y, Tran KN, et al. Localized male breast carcinoma and family history-an analysis of 142 patients. Cancer 1999; 86: 821–5.
   PubMed Web of Science ®Google Scholar
• Gough DB, Donohue JH, Evans MM, et al. A 50-year experience of male breast cancer: is outcome changing? Surg Oncol 1993; 2: 325–33.
   PubMedGoogle Scholar
• Cunha F, André S, Soares J. Morphology of male breast carcinoma in the evaluation of prognosis. Path Res Pract 1990; 186: 745–50.
   PubMedGoogle Scholar
• Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994; 39A: 930–5.
   Google Scholar
• Stierer M, Rosen H, WeitensfelderW, et al. Male breast cancer: Australian experience. Word J Surg 1995; 19: 687�92.
   Google Scholar
• Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulin-ius H. Male breast cancer in Iceland. Int .1- Cancer 1996; 65:
   Google Scholar
• Gattuso P, Reddy V B, Green L, et al. Prognostic significance of DNA ploidy in male breast carcinoma. Cancer 1992; 70:
   Google Scholar
• Donegan WL, Redlich PN. Breast cancer in men. Surg Clin North Am 1996; 76: 343–63.
   PubMed Web of Science ®Google Scholar
• Pich A, Margaria E, Chiusa L, Candelaresi G, Dal Canton O. Androgen receptor expression in male carcinoma: lack of clinicopathological association. Br J Cancer 1999; 75: 959–64.
   Google Scholar
• Dash RC, Ballo MS, Layfield U. Decay of androgen receptor immunoreactivity in archived tissue by using monoclonal antibody F39.4.1. Appl Immunohistochem 1998; 6: 145–9.
   Google Scholar
• Hatschek T, Wingren S, Carstensen J, Hultborn R. DNA content and S-phase fraction in male breast carcinomas. Acta Oncol 1994; 33: 609–13.
   PubMed Web of Science ®Google Scholar